Advertisement

Ischemic optic neuropathies — where are we now?

  • Sohan Singh HayrehEmail author
Review Article

Abstract

Ischemic optic neuropathy is of two types: anterior and posterior. Non-arteritic anterior ischemic optic neuropathy (NA-AION) is the most common type of ischemic optic neuropathy. There are three major misconceptions about NA-AION: (1) that its pathogenesis is not known, (2) that NA-AION and ischemic cerebral stroke are similar in nature, pathogenetically and in management, and (3) that there is no treatment. All these misconceptions are based on lack of in-depth knowledge of the subject. They are discussed in the light of our current scientific knowledge. The pathogenesis of NA-AION is known but is highly complex. NA-AION and ischemic cerebral stroke are very different clinical entities, pathogenetically and in management. Aspirin has no beneficial effect. Corticosteroid therapy during the initial stages can be beneficial. To reduce the risk of development of NA-AION in the other eye or of further visual loss in the same eye, it is essential to reduce as many risk factors as possible. Management of arteritic anterior ischemic optic neuropathy and of posterior ischemic optic neuropathy is discussed.

Keywords

Anterior ischemic optic neuropathy Giant cell arteritis Ischemic optic neuropathies Non-arteritic anterior ischemic optic neuropathy Optic nerve Posterior ischemic optic neuropathy 

Notes

Conflict of interest

The author has no conflict of interest of any kind.

References

  1. 1.
    Hayreh SS (1969) Blood supply of the optic nerve head and its role in optic atrophy, glaucoma and oedema of the optic disc. Br J Ophthalmol 53:721–748PubMedCrossRefGoogle Scholar
  2. 2.
    Hayreh SS (2001) The blood supply of the optic nerve head and the evaluation of it — myth and reality. Prog Retin Eye Res 20:563–593PubMedCrossRefGoogle Scholar
  3. 3.
    Hayreh SS, Vrabec F (1966) The structure of the head of the optic nerve in rhesus monkey. Am J Ophthalmol 61:136–150PubMedGoogle Scholar
  4. 4.
    Hayreh SS, Baines JAB (1972) Occlusion of the posterior ciliary artery. III. Effects on the optic nerve head. Br J Ophthalmol 56:754–764PubMedCrossRefGoogle Scholar
  5. 5.
    Hayreh SS (2011) Ischemic optic neuropathies. Springer, HeidelbergCrossRefGoogle Scholar
  6. 6.
    Hayreh SS (2009) Ischemic optic neuropathy. Prog Retin Eye Res 28:34–62PubMedCrossRefGoogle Scholar
  7. 7.
    Hayreh SS (2001) Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res 20:595–624PubMedCrossRefGoogle Scholar
  8. 8.
    Hayreh SS (1974) Anterior ischaemic optic neuropathy. I. Terminology and pathogenesis. Br J Ophthalmol 58:955–963PubMedCrossRefGoogle Scholar
  9. 9.
    Hayreh SS (1981) Posterior ischemic optic neuropathy. Ophthalmologica 182:29–41PubMedCrossRefGoogle Scholar
  10. 10.
    Hayreh SS (1996) Acute ischemic disorders of the optic nerve: pathogenesis, clinical manifestations and management. Ophthalmol Clin North Am 9:407–442Google Scholar
  11. 11.
    Hayreh SS, Joos KM, Podhajsky PA, Long CR (1994) Systemic diseases associated with non-arteritic anterior ischemic optic neuropathy. Am J Ophthalmol 118:766–780PubMedGoogle Scholar
  12. 12.
    Hayreh SS, Zimmerman MB (2008) Nonarteritic anterior ischemic optic neuropathy: clinical characteristics in diabetic patients versus nondiabetic patients. Ophthalmology 115:1818–1825PubMedCrossRefGoogle Scholar
  13. 13.
    Hayreh SS, Zimmerman MB, Podhajsky P, Alward WLM (1994) Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 117:603–624PubMedGoogle Scholar
  14. 14.
    Hayreh SS, Podhajsky PA, Zimmerman B (1999) Role of nocturnal arterial hypotension in optic nerve head ischemic disorders. Ophthalmologica 213:76–96PubMedCrossRefGoogle Scholar
  15. 15.
    Hayreh SS (1987) Anterior ischemic optic neuropathy. VIII. Clinical features and pathogenesis of post-hemorrhagic amaurosis. Ophthalmology 94:1488–1502PubMedGoogle Scholar
  16. 16.
    Hayreh SS (2012) Non-arteritic anterior ischemic optic neuropathy versus cerebral ischemic stroke. Graefes Arch Clin Exp Ophthalmol 250:1255–1260PubMedCrossRefGoogle Scholar
  17. 17.
    Hayreh SS, Podhajsky PA, Zimmerman B (1997) Non-arteritic anterior ischemic optic neuropathy — time of onset of visual loss. Am J Ophthalmol 124:641–647PubMedGoogle Scholar
  18. 18.
    Hayreh SS (1996) Duke–Elder Lecture: Systemic arterial blood pressure and the eye. Eye 10:5–28PubMedCrossRefGoogle Scholar
  19. 19.
    Hayreh SS (1999) Role of nocturnal arterial hypotension in the development of ocular manifestations of systemic arterial hypertension. Curr Opin Ophthalmol 10:474–482PubMedCrossRefGoogle Scholar
  20. 20.
    Hayreh SS (2009) Management of non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 247:1595–1600PubMedCrossRefGoogle Scholar
  21. 21.
    Ischemic Optic Neuropathy Decompression Trial Research Group (1995) Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 273:625–632CrossRefGoogle Scholar
  22. 22.
    Hayreh SS, Zimmerman MB (2008) Non-arteritic anterior ischemic optic neuropathy — natural history of visual outcome. Ophthalmology 115:298–305PubMedCrossRefGoogle Scholar
  23. 23.
    Beck RW, Hayreh SS, Podhajsky PA, Tan E-S, Moke PS (1997) Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 123:212–217PubMedGoogle Scholar
  24. 24.
    Newman NJ, Scherer R, Langenberg P, Kelman S, Feldon S, Kaufman D, Dickersin K; Ischemic Optic Neuropathy Decompression Trial Research Group (2002) The fellow eye in NAION: report from the Ischemic Optic Neuropathy Decompression Trial Follow-Up Study. Am J Ophthalmol 134:317–328CrossRefGoogle Scholar
  25. 25.
    Foulds WS (1969) Visual disturbances in systemic disorders: optic neuropathy and systemic disease. Trans Ophthalmol Soc UK 89:125–146Google Scholar
  26. 26.
    Hayreh SS (1974) Anterior ischaemic optic neuropathy. III. Treatment, prophylaxis, and differential diagnosis. Br J Ophthalmol 58:98l–989Google Scholar
  27. 27.
    Hayreh SS, Zimmerman MB (2008) Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol 246:1029–1046PubMedCrossRefGoogle Scholar
  28. 28.
    Hayreh SS (1977) Optic disc edema in raised intracranial pressure. V. Pathogenesis. Arch Ophthalmol 95:1553–1565PubMedCrossRefGoogle Scholar
  29. 29.
    Hayreh SS, Zimmerman MB (2007) Optic disc edema in non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 245:1107–1121PubMedCrossRefGoogle Scholar
  30. 30.
    Salgado C, Vilson F, Miller NR, Bernstein SL (2011) Cellular inflammation in nonarteritic anterior ischemic optic neuropathy and its primate model. Arch Ophthalmol 129:1583–1591PubMedCrossRefGoogle Scholar
  31. 31.
    Bernstein SL, Johnson MA, Miller NR (2011) Nonarteritic anterior ischemic optic neuropathy (NAION) and its experimental models. Prog Retin Eye Res 30:167–187PubMedCrossRefGoogle Scholar
  32. 32.
    Biousse V (2010) Steroids should not be offered to patients with nonarteritic anterior ischemic optic neuropathy. J Neuro-Ophthalmol 30:194–195CrossRefGoogle Scholar
  33. 33.
    Beri M, Klugman MR, Kohler JA, Hayreh SS (1987) Anterior ischemic optic neuropathy. VII. Incidence of bilaterality and various influencing factors. Ophthalmology 94:1020–1028PubMedGoogle Scholar
  34. 34.
    Hayreh SS, Podhajsky PA, Zimmerman B (2001) Ipsilateral recurrence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 132:734–742PubMedCrossRefGoogle Scholar
  35. 35.
    Hayreh SS, Zimmerman B (2013) Bilateral non-arteritic anterior ischemic optic neuropathy: comparison of visual outcome in the two eyes. J Neuro-Ophthalmol (In press)Google Scholar
  36. 36.
    Hayreh SS, Zimmerman B (2003) Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies. Ophthalmologica 217:239–259PubMedCrossRefGoogle Scholar
  37. 37.
    Hayreh SS, Podhajsky PA, Raman R, Zimmerman B (1997) Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 123:285–296PubMedGoogle Scholar
  38. 38.
    Hayreh SS, Podhajsky PA, Zimmerman B (1998) Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol 125:521–526,893PubMedCrossRefGoogle Scholar
  39. 39.
    Hayreh SS (1990) Anterior ischaemic optic neuropathy: differentiation of arteritic from non-arteritic type and its management. Eye 4:25–41PubMedCrossRefGoogle Scholar
  40. 40.
    Hayreh SS (2012) Treatment of acute visual loss in giant cell arteritis: should we prescribe high-dose intravenous steroids or just oral steroids? J Neuro-Ophthalmol 32:278–287CrossRefGoogle Scholar
  41. 41.
    Isayama Y, Takahashi T, Inoue M, Jimura T (1983) Posterior ischemic optic neuropathy. III. Clinical diagnosis. Ophthalmologica 187:141–147PubMedCrossRefGoogle Scholar
  42. 42.
    Sadda SR, Nee M, Miller NR, Biousse V, Newman NJ, Kouzis A (2001) Clinical spectrum of posterior ischemic optic neuropathy. Am J Ophthalmol 132:743–750PubMedCrossRefGoogle Scholar
  43. 43.
    Hayreh SS (2004) Posterior ischaemic optic neuropathy: clinical features, pathogenesis and management. Eye 18:1188–1206PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Department of Ophthalmology and Visual Sciences, College of MedicineUniversity of IowaIowa CityUSA
  2. 2.Department of Ophthalmology and Visual SciencesUniversity Hospitals & ClinicsIowa CityUSA

Personalised recommendations